Using serial observations to identify predictors of progression to AIDS in the Toronto Sexual Contact Study.

The Toronto Sexual Contact Study comprises a cohort of 249 male sexual contacts of men with HIV disease which has been followed every 3 months for almost 5 years. On enrollment 143 were seropositive and 16 seroconverted during the follow-up period. By 31 December 1989, 41 of the 159 seropositive cohort members had developed AIDS. Using Cox relative risk regression models, we investigated the association of a number of laboratory and clinical variables and progression to AIDS. Fixed covariate models examined laboratory variables from the enrollment visit of cohort members, with time calculated from this date. In models assessing time dependent covariates, time was calculated from the estimated date of HIV infection. In the univariate models of either fixed or time dependent covariates, many variables were significantly associated with risk of progression to AIDS (T4 cell count, T4/T8 ratio, blastogenic responses to phytohemagglutinin, concanavalin A, and pokeweed mitogen, serum IgA, appearance of p24 antigen, and the development of oral hairy leukoplakia, thrush, or herpes zoster). Appearance of persistent generalized lymphadenopathy was not associated with increased risk of progression. In the multivariate model which evaluated fixed laboratory covariates, T4/T8 ratio, IgA level, and PHA response at enrollment were significantly associated with elevated risk.(ABSTRACT TRUNCATED AT 250 WORDS)

[1]  D. Cox,et al.  Analysis of Survival Data. , 1985 .

[2]  C. Soskolne,et al.  The reliability of sexual histories in AIDS-related research: evaluation of an interview-administered questionnaire. , 1986, Canadian journal of public health = Revue canadienne de sante publique.

[3]  M A Fischl,et al.  The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. , 1987, The New England journal of medicine.

[4]  M A Fischl,et al.  The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. , 1987, The New England journal of medicine.

[5]  J. Montaner,et al.  Progression to AIDS and predictors of AIDS in seroprevalent and seroincident cohorts of homosexual men. , 1989, AIDS.

[6]  C. Petersen,et al.  Lymphocyte transformation response to pokeweed mitogen as a predictive marker for development of AIDS and AIDS related symptoms in homosexual men with HIV antibodies. , 1987, British medical journal.

[7]  A. Couroucé,et al.  Progression to AIDS in the majority of asymptomatic HIV-infected people. , 1989, AIDS.

[8]  R. Biggar,et al.  RISK OF AIDS AFTER HERPES ZOSTER , 1987, The Lancet.

[9]  J. Goudsmit,et al.  Risk of AIDS related complex and AIDS in homosexual men with persistent HIV antigenaemia. , 1987, British medical journal.

[10]  J. Goedert,et al.  Natural history of human immunodeficiency virus infections in hemophiliacs: effects of T-cell subsets, platelet counts, and age. , 1987, Annals of internal medicine.

[11]  J M Taylor,et al.  The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. , 1990, The New England journal of medicine.

[12]  J. Phair,et al.  Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. , 1987, The New England journal of medicine.

[13]  W. Saxinger,et al.  Four-year prospective study of homosexual men: correlation of immunologic abnormalities, clinical status, and serology to human immunodeficiency virus. , 1987, The Journal of infectious diseases.

[14]  J. Phair,et al.  The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group. , 1990, The New England journal of medicine.

[15]  J. Goudsmit,et al.  Appearance of predictors of disease progression in relation to the development of AIDS , 1989, AIDS.

[16]  M M Fanning,et al.  Validity of sexual histories in a prospective study of male sexual contacts of men with AIDS or an AIDS-related condition. , 1988, American journal of epidemiology.

[17]  D. Abrams,et al.  Persistent diffuse lymphadenopathy in homosexual men: endpoint or prodrome? , 1984, Annals of internal medicine.

[18]  R. Redfield,et al.  Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. , 1986, MMWR. Morbidity and mortality weekly report.

[19]  J. Godbold,et al.  Progression to AIDS in patients with lymphadenopathy or AIDS-related complex: reappraisal of risk and predictive factors. , 1989, The American journal of medicine.

[20]  Assessment of generalized lymphadenopathy in AIDS research: the degree of clinical agreement. , 1988, Journal of clinical epidemiology.

[21]  R. Chaisson,et al.  Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort , 1988, British medical journal.

[22]  N. Jewell,et al.  Patterns of T lymphocyte changes with human immunodeficiency virus infection: from seroconversion to the development of AIDS. , 1989, Journal of acquired immune deficiency syndromes.

[23]  R. Brookmeyer,et al.  The prevalent cohort study and the acquired immunodeficiency syndrome. , 1987, American journal of epidemiology.

[24]  D. Mildvan,et al.  Follow-up at 41/2 years on homosexual men with generalized lymphadenopathy. , 1985, The New England journal of medicine.

[25]  J. Malone,et al.  Sources of variability in repeated T-helper lymphocyte counts from human immunodeficiency virus type 1-infected patients: total lymphocyte count fluctuations and diurnal cycle are important. , 1990, Journal of acquired immune deficiency syndromes.

[26]  N. Dubin,et al.  CD4% is the best predictor of development of AIDS in a cohort of HIV‐infected homosexual men , 1991, AIDS.

[27]  C. Soskolne,et al.  A prospective study of male sexual contacts of men with AIDS-related conditions (ARC) or AIDS: HTLV-III antibody, clinical, and immune function status at induction. , 1986, Canadian journal of public health = Revue canadienne de sante publique.